Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
Go back to Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 252.75 +4.05 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.70 | 52 Week High | $160.00 | |||
| Open | $248.75 | 52 Week Low | $95.80 | |||
| Day High | $254.01 | P/E | 46.98 | |||
| Day Low | $248.55 | EPS | $5.38 | |||
| Volume | 172,291 | |||||
